Literature DB >> 27066111

Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia.

Marco Gentile1, Ilenia Calcaterra1, Alfonso Strazzullo1, Carmen Pagano1, Delia Pacioni1, Enza Speranza1, Paolo Rubba1, Gennaro Marotta1.   

Abstract

AIM: The aim of this study was to test small dense LDL changes with Armolipid Plus treatment in patients with familial combined hyperlipidemia (FCHL).
METHODS: After 4 weeks, 30 patients with FCHL were included in an 8-week, randomized, double-blind study and were taking, in addition to the standard diet, either placebo or Armolipid Plus.
RESULTS: The placebo group showed no statistically significant differences in the studied parameters; instead, in the Armolipid Plus group, statistically significant reduction differences were detected in BMI (p = 0.010), LDL score (p = 0.035) and an increase in mean LDL particle diameter (p = 0.040).
CONCLUSION: The combination of a standard diet with Armolipid Plus is able to reduce LDL score and increase LDL particle diameter in a group of FCHL after 8 weeks of treatment.

Entities:  

Keywords:  Armolipid Plus; familial combined hyperlipidemia; small dense LDL

Year:  2015        PMID: 27066111      PMCID: PMC4821502          DOI: 10.2217/clp.15.37

Source DB:  PubMed          Journal:  Clin Lipidol        ISSN: 1758-4302


  27 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

2.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

Authors:  C D Gardner; S P Fortmann; R M Krauss
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

3.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

Review 4.  Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

Authors:  Ioanna Gouni-Berthold; Heiner K Berthold
Journal:  Am Heart J       Date:  2002-02       Impact factor: 4.749

5.  Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts.

Authors:  R Menéndez; A M Amor; I Rodeiro; R M González; P C González; J L Alfonso; R Más
Journal:  Arch Med Res       Date:  2001 Jan-Feb       Impact factor: 2.235

6.  Berberine-induced LDLR up-regulation involves JNK pathway.

Authors:  Seahyoung Lee; Hyun-Joung Lim; Jin-Hee Park; Kuy-Sook Lee; Yangsoo Jang; Hyun-Young Park
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

7.  Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.

Authors:  Paolo Pauciullo; Marco Gentile; Gennaro Marotta; Angela Baiano; Stefania Ubaldi; Fabrizio Jossa; Gabriella Iannuzzo; Fulvio Faccenda; Salvatore Panico; Paolo Rubba
Journal:  Atherosclerosis       Date:  2008-07-12       Impact factor: 5.162

8.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

9.  LDL particle size distribution. Results from the Framingham Offspring Study.

Authors:  H Campos; E Blijlevens; J R McNamara; J M Ordovas; B M Posner; P W Wilson; W P Castelli; E J Schaefer
Journal:  Arterioscler Thromb       Date:  1992-12

10.  Efficacy of the National Cholesterol Education Program Step I diet. A randomized trial incorporating quick-service foods.

Authors:  M H Davidson; J C Kong; K B Drennan; K Story; G H Anderson
Journal:  Arch Intern Med       Date:  1996-02-12
View more
  3 in total

Review 1.  The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review.

Authors:  Sepide Talebi; Mohammad Bagherniya; Stephen L Atkin; Gholamreza Askari; Hossein M Orafai; Amirhossein Sahebkar
Journal:  Lipids Health Dis       Date:  2020-04-11       Impact factor: 3.876

2.  Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Arrigo F G Cicero; Cormac Kennedy; Tamara Knežević; Marilisa Bove; Coralie M G Georges; Agnė Šatrauskienė; Peter P Toth; Federica Fogacci
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

Review 3.  Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Aleksandra Stefanovic; Natasa Bogavac-Stanojevic; Ioannis Ilias; José Silva-Nunes; Anca Pantea Stoian; Andrej Janez; Manfredi Rizzo
Journal:  Pharmaceutics       Date:  2022-04-09       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.